Cyclarity Therapeutics, Inc.
Cyclarity Therapeutics, Inc.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Followed by an Open-label Patient Cohort | Arterial Occlusive Diseases, acute coronary syndrome, arteriosclerosis disorder, atherosclerosis, atherosclerotic cardiovascular disease, cardiovascular disorder, heart disorder, myocardial ischemia, vascular disorder | Recruiting | Early phase 1 | 2026-09-25 | NCT06813339 |